Urovant Sciences Ltd. UROV

Set alert

Price alert · UROV

All alert types
— — —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
531.75M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-3.09
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Feb 12, 2021
50-d avg
16.21
200-d avg
13.98
1y target
16.17

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for UROV has not been loaded yet. Try again in a moment.

Valuation

P/E -1.9×
FY 2017: -12.9×FY 2018: -9.5×FY 2019: -2.7×FY 2020: -1.9×
FY 2017 5y median -6.1× FY 2020
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×
FY 2017 5y median 0.0× FY 2020
P/B -4.8×
FY 2017: 89.5×FY 2018: 49.4×FY 2019: 4.0×FY 2020: -4.8×
FY 2017 5y median 26.7× FY 2020
P/FCF -2.7×
FY 2017: -13.8×FY 2018: -10.1×FY 2019: -2.7×FY 2020: -2.7×
FY 2017 5y median -6.4× FY 2020
EV/EBITDA -2.1×
FY 2017: -12.8×FY 2018: -9.3×FY 2019: -2.0×FY 2020: -2.1×
FY 2017 5y median -5.7× FY 2020
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×
FY 2017 5y median 0.0× FY 2020
FCF Yield -37.2%
FY 2017: -7.2%FY 2018: -9.9%FY 2019: -36.6%FY 2020: -37.2%
FY 2017 5y median -23.3% FY 2020

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2017 5y median 0.0% FY 2020
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2017 5y median 0.0% FY 2020
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2017 5y median 0.0% FY 2020
ROE 253.0%
FY 2017: -689.8%FY 2018: -524.1%FY 2019: -148.9%FY 2020: 253.0%
FY 2017 5y median -336.5% FY 2020
ROIC -441.3%
FY 2017: -692.2%FY 2018: -523.0%FY 2019: -125.5%FY 2020: -441.3%
FY 2017 5y median -482.2% FY 2020
ROA -231.8%
FY 2017: -564.7%FY 2018: -285.5%FY 2019: -111.2%FY 2020: -231.8%
FY 2017 5y median -258.7% FY 2020

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2017 FY 2020
Operating Income -28.9%
FY 2017: 0.0%FY 2018: -36.7%FY 2019: -199.4%FY 2020: -28.9%
FY 2017 FY 2020
EPS (diluted) -31.8%
FY 2017: 0.0%FY 2018: -36.7%FY 2019: -201.6%FY 2020: -31.8%
FY 2017 FY 2020
Free Cash Flow 6.2%
FY 2017: 0.0%FY 2018: -37.0%FY 2019: -216.8%FY 2020: 6.2%
FY 2017 FY 2020

Financial Health

Current Ratio 1.9×
FY 2017: 5.5×FY 2018: 2.1×FY 2019: 8.3×FY 2020: 1.9×
FY 2017 5y median 3.8× FY 2020
Quick Ratio 1.9×
FY 2017: 5.5×FY 2018: 2.1×FY 2019: 8.3×FY 2020: 1.9×
FY 2017 5y median 3.8× FY 2020
Debt / Equity -1.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: -1.5×
FY 2017 5y median 0.0× FY 2020
Net Debt / EBITDA -0.2×
FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.6×FY 2020: -0.2×
FY 2017 5y median 0.2× FY 2020
Interest Coverage 39.9×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 428×FY 2020: 39.9×
FY 2017 5y median 19.9× FY 2020

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2017 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2017 5y median 0.0% FY 2020

Annual · latest fiscal year ends 2020-03-31